Medical Cannabis Advocacy in Australia and New Zealand During the 1990s
How a small network of patients, doctors and HIV/AIDS activists pushed medical cannabis onto the policy agenda in Australasia.
The 1990s in Australia and New Zealand didn't produce legal medical cannabis — that took until the mid-2010s. But the decade mattered: HIV/AIDS patients, a few outspoken doctors, and groups like the Australian HEMP Party and NORML NZ forced the conversation into parliament and the press. A lot of folklore has grown around this period, including overstated claims about how close legalisation came. The reality is messier: serious inquiries happened, recommendations were made, and almost nothing was implemented.
Context at the start of the decade
At the start of the 1990s, cannabis was prohibited under criminal law in every Australian state and in New Zealand, with possession and cultivation routinely prosecuted under the Commonwealth Customs Act, state Drug Misuse Acts, and New Zealand's Misuse of Drugs Act 1975 [1][2]. Some jurisdictions had begun softening penalties for personal use — South Australia introduced an expiation (on-the-spot fine) scheme for small amounts in 1987, followed by the Australian Capital Territory in 1992 and the Northern Territory in 1996 [3]. None of these reforms touched medical use.
The medical conversation was largely driven from outside the medical establishment. Australian and New Zealand medical bodies in the early 1990s generally treated cannabis as a drug of abuse with no accepted therapeutic role, mirroring the position of the United States DEA at the time. There was no domestic pharmaceutical pathway: nabiximols (Sativex) did not exist yet, and dronabinol was not registered in either country.
The HIV/AIDS catalyst
As in San Francisco and New York, HIV/AIDS was the single biggest driver of medical cannabis advocacy in Australasia during the early-to-mid 1990s Strong evidence. Patients used cannabis to manage wasting syndrome, nausea from early antiretrovirals like AZT, and appetite loss. AIDS Councils in Sydney, Melbourne and Auckland quietly acknowledged this use in harm-reduction materials, though they stopped short of formal endorsement [4].
The Australian Federation of AIDS Organisations (AFAO) and state AIDS Councils lobbied through the National HIV/AIDS Strategy framework, which had bipartisan support and gave HIV advocates unusual policy access. This is the context in which medical cannabis first appeared in serious Australian government documents — not as a standalone reform, but as a harm-reduction question embedded in HIV policy [4]. The arrival of effective combination antiretroviral therapy in 1996 reduced the urgency of this specific advocacy line, but by then the topic had entered mainstream debate.
Key figures and organisations
Australia. The HEMP (Help End Marijuana Prohibition) Party, founded in 1993 by Michael Balderstone and others at the Nimbin MardiGrass, mixed recreational law reform with medical advocacy [5]. Dr Alex Wodak, then director of the Alcohol and Drug Service at St Vincent's Hospital in Sydney, was the most prominent medical voice arguing publicly for both harm reduction and legitimate medical access [6]. The Australian Drug Law Reform Foundation, which Wodak co-founded, made cannabis a recurring theme.
New Zealand. NORML New Zealand, active since 1979, ran patient-focused campaigns through the 1990s and published Norml News, which collected patient testimony [7]. The Aotearoa Legalise Cannabis Party (later the Aotearoa Legalise Cannabis Party / ALCP) was registered in 1996 and contested the 1996 MMP election, the first under proportional representation, receiving 1.66% of the party vote [8].
A persistent piece of folklore credits a single charismatic patient-activist with "almost getting medical cannabis legalised" in either country during this period Anecdote. No such moment is documented in Hansard or in the contemporaneous press. Advocacy was diffuse and incremental.
Official inquiries
Two government processes from this decade are worth knowing about.
The National Task Force on Cannabis, established by the Commonwealth Department of Human Services and Health, produced a major report in 1994 (The Health and Psychological Consequences of Cannabis Use, Hall, Solowij and Lemon) [9]. It was primarily a health-effects review rather than a medical-use review, but it acknowledged therapeutic research in nausea, glaucoma and spasticity and called for more research — a notable shift from earlier government documents.
In New South Wales, Premier Bob Carr commissioned a Working Party on the Use of Cannabis for Medical Purposes, which reported in August 2000 [10]. Though its report fell just outside the 1990s, the working party was a direct product of late-1990s advocacy. It recommended a trial scheme allowing patients with specified conditions to use cannabis without criminal penalty. The NSW government accepted the recommendations in principle in 2003 but never implemented them — a pattern that would repeat across Australasia for another decade.
Myths that grew out of the era
Several persistent claims about the 1990s don't survive contact with the primary record:
- "Medical cannabis was about to be legalised in NSW in 2000." The Working Party recommended a trial, not legalisation, and the trial never ran [10]. Disputed
- "Helen Clark's Labour government nearly decriminalised cannabis." The Health Select Committee inquiry that produced a 1998 report on cannabis policy was initiated under the National-led government, and its recommendations were modest; subsequent Labour governments did not act on decriminalisation [11]. Disputed
- "Nimbin had de facto medical dispensaries in the 1990s." Nimbin had an open cannabis market and the HEMP Embassy, but no documented medical dispensing operation comparable to the San Francisco Cannabis Buyers Club [5]. Weak / limited
The broader myth — that the 1990s were a near-miss for legal medical access in Australasia — overstates the political reality. What the decade actually produced was the vocabulary and the advocacy infrastructure that the 2010s reforms drew on.
Legacy
Australia did not establish a federal medicinal cannabis access scheme until the Narcotic Drugs Amendment Act 2016, and New Zealand's Misuse of Drugs (Medicinal Cannabis) Amendment Act passed in 2018 [12][13]. By then, most of the 1990s advocates were either retired, deceased, or had moved on to other reform issues. The people who got medical cannabis over the line in the 2010s — patient parents campaigning for paediatric epilepsy access, palliative care physicians, and a new generation of politicians — built on but largely did not directly continue the 1990s networks.
For anyone researching this period, the best primary sources are Hansard records from the Australian Senate and the NSW and Victorian parliaments, the Norml News archive, and the contemporaneous reporting in The Sydney Morning Herald, The Age and the New Zealand Herald. Patient testimony from the HIV/AIDS years is preserved in AIDS Council archives and in the Australian Lesbian and Gay Archives.
Sources
- Government Australian Institute of Health and Welfare. National Drug Strategy Household Survey historical reports. Canberra: AIHW.
- Government New Zealand Parliamentary Counsel Office. Misuse of Drugs Act 1975.
- Peer-reviewed Hughes CE. Australian Threshold Quantities for 'Drug Trafficking': Are They Placing Drug Users at Risk of Unjustified Sanction? Trends & Issues in Crime and Criminal Justice, no. 467, 2014.
- Government Commonwealth Department of Health and Aged Care. National HIV/AIDS Strategy 1996-97 to 1998-99. Canberra: AGPS, 1996.
- Reported Dunlevy S. 'Nimbin's MardiGrass marks 25 years of pot protest.' The Sydney Morning Herald, 2 May 2018.
- Peer-reviewed Wodak A, Owens R. Drug Prohibition: A Call for Change. UNSW Press, 1996.
- Reported NORML New Zealand. Organisational history and Norml News archive.
- Government New Zealand Electoral Commission. 1996 General Election Official Results.
- Government Hall W, Solowij N, Lemon J. The Health and Psychological Consequences of Cannabis Use. National Drug Strategy Monograph Series No. 25. Canberra: AGPS, 1994.
- Government NSW Parliament. Working Party on the Use of Cannabis for Medical Purposes: Report, August 2000.
- Government New Zealand House of Representatives Health Committee. Inquiry into the Mental Health Effects of Cannabis, 1998.
- Government Commonwealth of Australia. Narcotic Drugs Amendment Act 2016.
- Government New Zealand Parliament. Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.